Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03364803 · ClinicalTrials.gov registry record
Collecting Information About Treatment Results for Patients With Cushing's Syndrome
A clinical trial of Cushing Syndrome and Cushing Disease, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 300
- Enrollment target
- 7
- Study locations
NCT03364803: Recruiting study of Cushing Syndrome and Cushing Disease, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03364803 is a study of Cushing Syndrome and Cushing Disease that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 300 participants, above the 147-participant average among 9 other Cushing Syndrome trials with a reported enrollment target (104% higher). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03364803, a study of Cushing Syndrome and Cushing Disease, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to follow participants with Cushing's syndrome during the course of their routine care and to form a data registry to study long term participant outcomes.
Conditions Studied
Interventions
- OTHER Cushing's QoL (Quality of Life Questionnaire)
- OTHER Nottingham Health Profile (NHP)
- OTHER Hospital Anxiety and Depression Scale (HADS)
- OTHER Perceived Stress Scale (PSS)
- OTHER Barratt's Impulsivity Scale (BIS)
Study Locations (7)
New York
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) - Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities) - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau (Limited Protocol Activities) - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) - Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2017-11-28 |
| Est. Completion | 2026-11-28 |
What NCT03364803 shows while recruiting
NCT03364803 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 147-participant average among 9 other Cushing Syndrome trials with a reported enrollment target (104% higher).
The record links to 3 conditions, with Cushing Syndrome appearing as the primary indexed condition, and to 5 interventions - of which Cushing's QoL (Quality of Life Questionnaire) is the first listed.
NCT03364803 lists 7 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT03364803 about?
NCT03364803 is a clinical study titled "Collecting Information About Treatment Results for Patients With Cushing's Syndrome". The purpose of this study is to follow participants with Cushing's syndrome during the course of their routine care and to form a data registry to study long term participant outcomes.
What is the current status of trial NCT03364803?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2017-11-28. Estimated completion is 2026-11-28.
What conditions does trial NCT03364803 study?
This clinical trial studies the following conditions: Cushing Syndrome, Cushing Disease, Cushing's Disease.
What interventions are being tested in trial NCT03364803?
The interventions under investigation include: Cushing's QoL (Quality of Life Questionnaire) (OTHER), Nottingham Health Profile (NHP) (OTHER), Hospital Anxiety and Depression Scale (HADS) (OTHER), Perceived Stress Scale (PSS) (OTHER), Barratt's Impulsivity Scale (BIS) (OTHER).
Who is sponsoring clinical trial NCT03364803?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03364803 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cushing Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03364803's enrollment target sits among peer trials
300 2nd of 9 the highest of 9 other Cushing Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cushing Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
RECRUITING · Phase 2
-
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
RECRUITING · Phase 1
-
Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS)
RECRUITING
-
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
RECRUITING · Phase 2
-
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
ACTIVE NOT RECRUITING · Phase 2
-
Open-label Treatment in Cushing's Syndrome
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI